PMIs are associated with increased future mortality. Whether PMI is simply a marker for more extensive coronary artery disease or the actual myocardial necrosis is accounting for the increased mortality is unknown. In either case, it would be of benefit to identify these patients before PCI and incorporate approaches during the intervention to limit or prevent elevation of cTn and CPK-MB.
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Approaches of proven benefit include pre-treatment with high-dose statin therapy and oral dual antiplatelet therapy, and treatments during PCI including distal protection devices, glycoprotein IIb/IIIa inhibition, and pre-conditioning.
Because it is the lipid-filled plaque that is responsible for distal embolization with secondary platelet activation and aggregation, one approach to preidentify these individuals is through the use of invasive imaging techniques at the time of intervention (3). These include attenuated plaques by gray-scale intravascular ultrasound (IVUS), the necrotic core by radiofrequency IVUS, the thin-capped fibroatheroma (TCFA) by optical coherence tomography (OCT), and the large lipid core plaque by near-infrared spectroscopy (NIRS). The search for which of these approaches will best predict PMI, including the use of combinations of these approaches, is the goal of the 2 articles in this issue of JACC: Cardiovascular Interventions (4,5). that she has no relationships relevant to the contents of this paper to disclose. feldmanm@uthscsa.edu.
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